This post-hoc analysis of a 12-week study evaluated the apoB : LDL-C and apoB : non-HDL-C correlations in dyslipidemic patients randomized equally to double-blind ERN/LRPT 1 g/20 mg , SIMVA 10 , 20 , or 40 mg , or ERN/LRPT 1 g/20 mg + SIMVA ( 10 , 20 , or 40 mg ) once daily for 4 weeks .